{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:45:08Z","timestamp":1776462308746,"version":"3.51.2"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T00:00:00Z","timestamp":1316736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Signalling by fibroblast growth factor receptor type 2 (FGFR2) normally involves a tissue-specific alternative splice choice between two exons (IIIb and IIIc), which generates two receptor isoforms (FGFR2b and FGFR2c respectively) with differing repertoires of FGF-binding specificity. Here we describe a unique chimeric IIIb\/c exon in a patient with Apert syndrome, generated by a non-allelic homologous recombination event.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Presentation<\/jats:title><jats:p>We present a child with Apert syndrome in whom routine genetic testing had excluded the<jats:italic>FGFR2<\/jats:italic>missense mutations commonly associated with this disorder. The patient was found to harbour a heterozygous 1372 bp deletion between<jats:italic>FGFR2<\/jats:italic>exons IIIb and IIIc, apparently originating from recombination between 13 bp of identical DNA sequence present in both exons. The rearrangement was not present in the unaffected parents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Based on the known pathogenesis of Apert syndrome, the chimeric FGFR2 protein is predicted to act in a dominant gain-of-function manner. This is likely to result from its expression in mesenchymal tissues, where retention of most of the residues essential for FGFR2b binding activity would result in autocrine activation. This report adds to the repertoire of rare cases of Apert syndrome for which a pathogenesis based on atypical<jats:italic>FGFR2<\/jats:italic>rearrangements can be demonstrated.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2350-12-122","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T18:14:28Z","timestamp":1316801668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A deletion of FGFR2 creating a chimeric IIIb\/IIIc exon in a child with Apert syndrome"],"prefix":"10.1186","volume":"12","author":[{"given":"Aimee L","family":"Fenwick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C","family":"Bowdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regan EM","family":"Klatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew OM","family":"Wilkie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,23]]},"reference":[{"key":"857_CR1","first-page":"316","volume-title":"Craniosynostosis Diagnosis, Evaluation, and Management","author":"MJ Cohen","year":"2000","unstructured":"Cohen MJ: Apert Syndrome. Craniosynostosis Diagnosis, Evaluation, and Management. Edited by: Cohen MJ, MacLean R. 2000, Oxford: Oxford University Press, 316-354. 2","edition":"2"},{"issue":"2","key":"857_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng0295-165","volume":"9","author":"AO Wilkie","year":"1995","unstructured":"Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcolm S, Winter RM, Reardon W: Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet. 1995, 9 (2): 165-172. 10.1038\/ng0295-165.","journal-title":"Nat Genet"},{"issue":"2","key":"857_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cytogfr.2005.03.001","volume":"16","author":"AO Wilkie","year":"2005","unstructured":"Wilkie AO: Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev. 2005, 16 (2): 187-203. 10.1016\/j.cytogfr.2005.03.001.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"857_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cytogfr.2005.02.003","volume":"16","author":"DM Ornitz","year":"2005","unstructured":"Ornitz DM: FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 2005, 16 (2): 205-213. 10.1016\/j.cytogfr.2005.02.003.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"857_CR5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.PRS.0000146703.08958.95","volume":"115","author":"OA Ibrahimi","year":"2005","unstructured":"Ibrahimi OA, Chiu ES, McCarthy JG, Mohammadi M: Understanding the molecular basis of Apert syndrome. Plast Reconstr Surg. 2005, 115 (1): 264-270.","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"857_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ajmg.10775","volume":"112","author":"AO Wilkie","year":"2002","unstructured":"Wilkie AO, Patey SJ, Kan SH, van den Ouweland AM, Hamel BC: FGFs, their receptors, and human limb malformations: clinical and molecular correlations. Am J Med Genet. 2002, 112 (3): 266-278. 10.1002\/ajmg.10775.","journal-title":"Am J Med Genet"},{"issue":"2","key":"857_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.01.008","volume":"16","author":"M Mohammadi","year":"2005","unstructured":"Mohammadi M, Olsen SK, Ibrahimi OA: Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 2005, 16 (2): 107-137. 10.1016\/j.cytogfr.2005.01.008.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"23","key":"857_CR8","doi-asserted-by":"publisher","first-page":"15694","DOI":"10.1074\/jbc.M601252200","volume":"281","author":"X Zhang","year":"2006","unstructured":"Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM: Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem. 2006, 281 (23): 15694-15700. 10.1074\/jbc.M601252200.","journal-title":"J Biol Chem"},{"issue":"5","key":"857_CR9","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1073\/pnas.0436500100","volume":"100","author":"BK Yeh","year":"2003","unstructured":"Yeh BK, Igarashi M, Eliseenkova AV, Plotnikov AN, Sher I, Ron D, Aaronson SA, Mohammadi M: Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proc Natl Acad Sci USA. 2003, 100 (5): 2266-2271. 10.1073\/pnas.0436500100.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"857_CR10","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/hmg\/7.9.1475","volume":"7","author":"J Anderson","year":"1998","unstructured":"Anderson J, Burns HD, Enriquez-Harris P, Wilkie AO, Heath JK: Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet. 1998, 7 (9): 1475-1483. 10.1093\/hmg\/7.9.1475.","journal-title":"Hum Mol Genet"},{"issue":"13","key":"857_CR11","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1073\/pnas.121183798","volume":"98","author":"OA Ibrahimi","year":"2001","unstructured":"Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M: Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci USA. 2001, 98 (13): 7182-7187. 10.1073\/pnas.121183798.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"857_CR12","doi-asserted-by":"publisher","first-page":"14536","DOI":"10.1073\/pnas.97.26.14536","volume":"97","author":"K Yu","year":"2000","unstructured":"Yu K, Herr AB, Waksman G, Ornitz DM: Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci USA. 2000, 97 (26): 14536-14541. 10.1073\/pnas.97.26.14536.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"857_CR13","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/hmg\/ddh235","volume":"13","author":"OA Ibrahimi","year":"2004","unstructured":"Ibrahimi OA, Zhang F, Eliseenkova AV, Itoh N, Linhardt RJ, Mohammadi M: Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum Mol Genet. 2004, 13 (19): 2313-2324. 10.1093\/hmg\/ddh235.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"857_CR14","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1073\/pnas.081082498","volume":"98","author":"K Yu","year":"2001","unstructured":"Yu K, Ornitz DM: Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes. Proc Natl Acad Sci USA. 2001, 98 (7): 3641-3643. 10.1073\/pnas.081082498.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"857_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/humu.20825","volume":"30","author":"EG Bochukova","year":"2009","unstructured":"Bochukova EG, Roscioli T, Hedges DJ, Taylor IB, Johnson D, David DJ, Deininger PL, Wilkie AO: Rare mutations of FGFR2 causing apert syndrome: identification of the first partial gene deletion, and an Alu element insertion from a new subfamily. Hum Mutat. 2009, 30 (2): 204-211. 10.1002\/humu.20825.","journal-title":"Hum Mutat"},{"issue":"2","key":"857_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1086\/302245","volume":"64","author":"M Oldridge","year":"1999","unstructured":"Oldridge M, Zackai EH, McDonald-McGinn DM, Iseki S, Morriss-Kay GM, Twigg SR, Johnson D, Wall SA, Jiang W, Theda C, Jabs EW, Wilkie AO: De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet. 1999, 64 (2): 446-461. 10.1086\/302245.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"857_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/dvdy.21648","volume":"238","author":"MK Hajihosseini","year":"2009","unstructured":"Hajihosseini MK, Duarte R, Pegrum J, Donjacour A, Lana-Elola E, Rice DP, Sharpe J, Dickson C: Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model. Dev Dyn. 2009, 238 (2): 376-385. 10.1002\/dvdy.21648.","journal-title":"Dev Dyn"},{"issue":"7","key":"857_CR18","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1073\/pnas.071586898","volume":"98","author":"MK Hajihosseini","year":"2001","unstructured":"Hajihosseini MK, Wilson S, De Moerlooze L, Dickson C: A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert\/Pfeiffer-syndrome-like phenotypes. Proc Natl Acad Sci USA. 2001, 98 (7): 3855-3860. 10.1073\/pnas.071586898.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"857_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1128\/MCB.25.1.250-263.2005","volume":"25","author":"RH Hovhannisyan","year":"2005","unstructured":"Hovhannisyan RH, Carstens RP: A novel intronic cis element, ISE\/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence. Mol Cell Biol. 2005, 25 (1): 250-263. 10.1128\/MCB.25.1.250-263.2005.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"857_CR20","doi-asserted-by":"publisher","first-page":"e10946","DOI":"10.1371\/journal.pone.0010946","volume":"5","author":"A Takeuchi","year":"2010","unstructured":"Takeuchi A, Hosokawa M, Nojima T, Hagiwara M: Splicing reporter mice revealed the evolutionally conserved switching mechanism of tissue-specific alternative exon selection. PLoS One. 2010, 5 (6): e10946-10.1371\/journal.pone.0010946.","journal-title":"PLoS One"},{"issue":"5","key":"857_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.molcel.2009.01.025","volume":"33","author":"CC Warzecha","year":"2009","unstructured":"Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP: ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell. 2009, 33 (5): 591-601. 10.1016\/j.molcel.2009.01.025.","journal-title":"Mol Cell"},{"issue":"1","key":"857_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/BJ20100884","volume":"436","author":"LM Wheldon","year":"2011","unstructured":"Wheldon LM, Khodabukus N, Patey SJ, Smith TG, Heath JK, Hajihosseini MK: Identification and characterization of an inhibitory fibroblast growth factor receptor 2 (FGFR2) molecule, up-regulated in an Apert Syndrome mouse model. Biochem J. 2011, 436 (1): 71-81. 10.1042\/BJ20100884.","journal-title":"Biochem J"},{"issue":"4","key":"857_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0092-8674(00)80851-X","volume":"101","author":"AN Plotnikov","year":"2000","unstructured":"Plotnikov AN, Hubbard SR, Schlessinger J, Mohammadi M: Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell. 2000, 101 (4): 413-424. 10.1016\/S0092-8674(00)80851-X.","journal-title":"Cell"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-12-122\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T23:05:48Z","timestamp":1686351948000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-12-122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,23]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-12-122","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,23]]},"assertion":[{"value":"25 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"122"}}